Literature DB >> 15318118

Nitric oxide synthesis inhibition attenuates conditioned reinstatement of ethanol-seeking, but not the primary reinforcing effects of ethanol.

Xiu Liu1, Friedbert Weiss.   

Abstract

BACKGROUND: Nitric oxide (NO) signaling has been implicated in regulating aspects of the reinforcing and addictive actions of cocaine. These experiments were designed to examine whether NO-dependent neurotransmission also participates in mediating the addictive actions of another drug of abuse, ethanol, with emphasis on both the primary reinforcing effects of ethanol and the incentive motivational effects of ethanol-related contextual stimuli.
METHODS: Male Wistar rats were operantly trained to orally self-administer 10% (w/v) ethanol in daily 30-min sessions and to associate distinct discriminative stimuli with the availability of ethanol (S+) versus nonreward (S-). Rats were treated with the NO synthase inhibitor NG-nitro-L-arginine methyl ester (L-NAME; 0, 10, or 40 mg/kg intraperitoneally) 30 min before self-administration tests that were conducted after establishment of stable levels of daily ethanol intake and conditioned reinstatement tests that were performed after extinction of ethanol-maintained operant responding.
RESULTS: L-NAME did not alter the primary reinforcing effects of ethanol in self-administration tests. In contrast, L-NAME dose-dependently attenuated the recovery of extinguished responding induced by the ethanol S in the absence of ethanol availability during reinstatement tests.
CONCLUSIONS: These results suggest that the NO system does not play a role in behavior reinforced directly by ethanol. However, the results implicate NO-dependent neurotransmission in alcohol-seeking responses elicited by drug-related contextual stimuli. Copyright 2004 Research Society on Alcoholism

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15318118     DOI: 10.1097/01.alc.0000134219.93192.00

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  7 in total

1.  Stress enhancement of craving during sobriety: a risk for relapse.

Authors:  George R Breese; Kathleen Chu; Christopher V Dayas; Douglas Funk; Darin J Knapp; George F Koob; Dzung Anh Lê; Laura E O'Dell; David H Overstreet; Amanda J Roberts; Rajita Sinha; Glenn R Valdez; Friedbert Weiss
Journal:  Alcohol Clin Exp Res       Date:  2005-02       Impact factor: 3.455

2.  Mecamylamine attenuates cue-induced reinstatement of nicotine-seeking behavior in rats.

Authors:  Xiu Liu; Anthony R Caggiula; Susan K Yee; Hiroko Nobuta; Alan F Sved; Robert N Pechnick; Russell E Poland
Journal:  Neuropsychopharmacology       Date:  2006-06-21       Impact factor: 7.853

3.  Naltrexone attenuation of conditioned but not primary reinforcement of nicotine in rats.

Authors:  Xiu Liu; Matthew I Palmatier; Anthony R Caggiula; Alan F Sved; Eric C Donny; Maysa Gharib; Sheri Booth
Journal:  Psychopharmacology (Berl)       Date:  2008-09-21       Impact factor: 4.530

4.  Effects of blockade of α4β2 and α7 nicotinic acetylcholine receptors on cue-induced reinstatement of nicotine-seeking behaviour in rats.

Authors:  Xiu Liu
Journal:  Int J Neuropsychopharmacol       Date:  2013-08-19       Impact factor: 5.176

5.  Reinstatement of ethanol and sucrose seeking by the neurosteroid allopregnanolone in C57BL/6 mice.

Authors:  Deborah A Finn; Gregory P Mark; Andrea M Fretwell; Katherine R Gililland-Kaufman; Moriah N Strong; Matthew M Ford
Journal:  Psychopharmacology (Berl)       Date:  2008-08-30       Impact factor: 4.530

6.  Targeting the α4β2- and α7-Subtypes of Nicotinic Acetylcholine Receptors for Smoking Cessation Medication Development.

Authors:  Lakshmi Ramachandran Nair; Xiu Liu
Journal:  J Addict Res Ther       Date:  2019-04-15

Review 7.  The Winding Road to Relapse: Forging a New Understanding of Cue-Induced Reinstatement Models and Their Associated Neural Mechanisms.

Authors:  Mark D Namba; Seven E Tomek; M Foster Olive; Joshua S Beckmann; Cassandra D Gipson
Journal:  Front Behav Neurosci       Date:  2018-02-09       Impact factor: 3.558

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.